文献速递肿瘤 PET/CT

呼吸门控4D 18F-FDG PET/CT在肝脏病灶检测中的附加诊断价值:一项多中心研究

Added diagnostic value of respiratory-gated 4D 18F-FDG PET/CT in the detection of liver lesions: a multicenter study.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2017-08-19

这项欧洲五中心回顾性研究纳入56例肿瘤患者,对比标准3D PET/CT与肝脏4D PET/CT对72个肝脏病灶的诊断价值。4D PET/CT减少了不确定病灶(1/72 vs 19/72),提高了诊断准确率(95.4% vs 83.1%,将不确定病灶计为阳性时)和病灶SUVmax(6.9±3.2 vs 5.2±2.3,p<0.001)。

要点

  • 4D PET/CT将不确定病灶从3D的19/72(26.4%)降至1/72(1.4%)。
  • 将不确定病灶计为阳性时,4D较3D提高诊断准确率(95.4% vs 83.1%)。
  • 4D PET/CT肝脏病灶SUVmax显著高于3D(6.9±3.2 vs 5.2±2.3,p<0.001)。

核心结论

  • 呼吸门控PET/CT技术是诊断肝脏病灶的有价值临床工具,可减少3D不确定发现、提高诊断准确率和报告信心。
  • 4D PET/CT还改善了肝脏病灶SUVmax的定量。

研究设计与样本

  • 欧洲五中心回顾性研究,纳入56例肿瘤患者(29例男性、27例女性,平均年龄61.2±11.2岁),均接受标准3D PET/CT和肝脏4D PET/CT。
  • 以组织学和临床随访为标准参考,对比两种技术的诊断准确率。

主要发现

  • 共分析72个肝脏病灶;3D PET/CT视觉分析阳性32/72(44.4%)、阴性21/72(29.2%)、不确定19/72(26.4%)。
  • 4D PET/CT视觉分析阳性48/72(66.7%)、阴性23/72(31.9%)、不确定1/72(1.4%)。
  • 4D PET/CT在37/72(51.4%)病灶中提高了病灶定性的信心。
  • 将不确定病灶计为阳性时,3D PET/CT敏感性88.9%、特异性70.0%、准确率83.1%;计为阴性时分别为67.7%、90.0%、73.8%。
  • 4D PET/CT将不确定病灶计为阳性时敏感性97.8%、特异性90.0%、准确率95.4%;计为阴性时分别为95.6%、90.0%、93.8%。

临床怎么用

  • 原文结论认为呼吸门控PET/CT技术是诊断肝脏病灶的有价值临床工具,可减少3D不确定发现、提高诊断准确率和报告信心。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of the present study was to evaluate the added diagnostic value of respiratory-gated 4D18F-FDG PET/CT in liver lesion detection and characterization in a European multicenter retrospective study. METHODS: Fifty-six oncological patients (29 males and 27 females, mean age, 61.2 ± 11.2 years) from five European centers, submitted to standard 3D-PET/CT and liver 4D-PET/CT were retrospectively evaluated. Based on visual analysis, liver PET/CT findings were scored as positive, negative, or equivocal both in 3D and 4D PET/CT. The impact of 4D-PET/CT on the confidence in classifying liver lesions was assessed. PET/CT findings were compared to histology and clinical follow-up as standard reference and diagnostic accuracy was calculated for both techniques. At semi-quantitative analysis, SUVmax was calculated for each detected lesion in 3D and 4D-PET/CT. RESULTS: Overall, 72 liver lesions were considered for the analysis. Based on visual analysis in 3D-PET/CT, 32/72 (44.4%) lesions were considered positive, 21/72 (29.2%) negative, and 19/72 (26.4%) equivocal, while in 4D-PET/CT 48/72 (66.7%) lesions were defined positive, 23/72 (31.9%) negative, and 1/72 (1.4%) equivocal. 4D-PET/CT findings increased the confidence in lesion definition in 37/72 lesions (51.4%). Considering 3D equivocal lesions as positive, sensitivity, specificity, and accuracy were 88.9, 70.0, and 83.1%, respectively, while the same figures were 67.7, 90.0, and 73.8% if 3D equivocal findings were included as negative. 4D-PET/CT sensitivity, specificity, and accuracy were 97.8, 90.0, and 95.4%, respectively, considering equivocal lesions as positive and 95.6, 90.0, and 93.8% considering equivocal lesions as negative. The SUVmax of the liver lesions in 4D-PET (mean ± SD, 6.9 ± 3.2) was significantly higher (p < 0.001) than SUVmax in 3D-PET (mean ± SD, 5.2 ± 2.3). CONCLUSIONS: Respiratory-gated PET/CT technique is a valuable clinical tool in diagnosing liver lesions, reducing 3D undetermined findings, improving diagnostic accuracy, and confidence in reporting. 4D-PET/CT also improved the quantification of SUVmax of liver lesions.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Crivellaro C, De Ponti E, Elisei F, et al. Added diagnostic value of respiratory-gated 4D 18F-FDG PET/CT in the detection of liver lesions: a multicenter study. Eur J Nucl Med Mol Imaging. 2017. PMID: 28825125. doi:10.1007/s00259-017-3795-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。